Axa’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-142,400
| Closed | -$533K | – | 1077 |
|
|
2023
Q3 | $533K | Hold |
142,400
| – | – | ﹤0.01% | 930 |
|
|
2023
Q2 | $608K | Buy |
+142,400
| New | +$608K | ﹤0.01% | 923 |
|
|
2019
Q1 | – | Sell |
-58,779
| Closed | -$532K | – | 1320 |
|
|
2018
Q4 | $532K | Sell |
58,779
-350,104
| -86% | -$3.17M | ﹤0.01% | 1077 |
|
|
2018
Q3 | $6.75M | Hold |
408,883
| – | – | 0.02% | 587 |
|
|
2018
Q2 | $5.72M | Buy |
408,883
+5,203
| +1% | +$72.8K | 0.02% | 620 |
|
|
2018
Q1 | $4.46M | Sell |
403,680
-3,974
| -1% | -$43.9K | 0.02% | 682 |
|
|
2017
Q4 | $3.59M | Sell |
407,654
-406
| -0.1% | -$3.57K | 0.01% | 733 |
|
|
2017
Q3 | $5.45M | Sell |
408,060
-5,668
| -1% | -$75.7K | 0.02% | 605 |
|
|
2017
Q2 | $5.94M | Buy |
413,728
+44,976
| +12% | +$645K | 0.03% | 563 |
|
|
2017
Q1 | $7.8M | Buy |
368,752
+59,019
| +19% | +$1.25M | 0.04% | 485 |
|
|
2016
Q4 | $8.72M | Buy |
309,733
+5,911
| +2% | +$166K | 0.04% | 440 |
|
|
2016
Q3 | $8.14M | Sell |
303,822
-103,770
| -25% | -$2.78M | 0.04% | 461 |
|
|
2016
Q2 | $6.88M | Sell |
407,592
-41,197
| -9% | -$696K | 0.03% | 494 |
|
|
2016
Q1 | $9.53M | Buy |
+448,789
| New | +$9.53M | 0.04% | 401 |
|